Besides interactions of PPARα and TET enzymes in early development, associations of PPARα inhibition with the increased expression of DNA methyltransferase I (DNMT1) and protein arginine methyltransferase 6 (PRMT6) have already been demonstrated in colon cancer and the liver [129,130]. Here, PRMT6 is linked to malignant colon neoplasm.